| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 15, 2006
Revised on October 9, 2006
Accepted on October 24, 2006
-Catenin/T-Cell Factor Signaling Involves Modulation of Cyclin D1 and p21 Expression
From the Bristol Heart Institute (H.Q., S.C.S., C.A.B., G.B.S.-N., S.J.G.), Level 7, Bristol Royal Infirmary, Upper Maudlin St, BRISTOL, BS2 8HW, UK, Cardiovascular Branch (M.B.), National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland.
* To whom correspondence should be addressed. E-mail: s.j.george{at}bris.ac.uk.
We previously observed that stimulation of vascular smooth muscle cell (VSMC) proliferation with growth factors is associated with dismantling of cadherin junctions and nuclear translocation of
-catenin. In this study we demonstrate directly that growth factors stimulate
-catenin/T-cell factor (TCF) signaling in primary VSMCs. To determine whether
-catenin/TCF signaling regulates VSMC proliferation via modulation of the
-catenin/TCF responsive cell cycle genes, cyclin D1 and p21, we inhibited
-catenin/TCF signaling by adenoviral-mediated over-expression of N-Cadherin, ICAT (an endogenous inhibitor of
-catenin/TCF signaling), or a dominant negative (dn) mutant of TCF-4. N-cadherin, ICAT or dnTCF-4 over-expression significantly reduced proliferation of isolated human VSMCs by approximately 55%, 80%, and 45% respectively. Similar effects were observed in human saphenous vein medial segments where proliferation was reduced by approximately 55%. Transfection of dnTCF-4 in the ISS10 human VSMC line significantly lowered TCF and cyclin D1 reporter activity but significantly elevated p21 reporter activity, indicating regulation of these genes by
-catenin/TCF signaling. In support of this, over-expression of N-cadherin, ICAT or dnTCF-4 in isolated human VSMCs significantly lowered levels of cyclin D1 mRNA and protein levels. In contrast, over-expression of N-Cadherin, ICAT or dnTCF4 significantly elevated p21 mRNA and protein levels. In summary, we have demonstrated that increasing N-cadherin and inhibiting
-catenin/TCF signaling reduces VSMC proliferation, decreases the expression of cyclin D1 and increases levels of the cell cycle inhibitor, p21. We therefore suggest that the N-cadherin and
-catenin/TCF signaling pathway is a key modulator of VSMC proliferation via regulation of these 2
-catenin/TCF responsive genes.
Related Article:
This article has been cited by other articles:
![]() |
M. He, M. Han, B. Zheng, Y.-N. Shu, and J.-K. Wen Angiotensin II Stimulates KLF5 Phosphorylation and its Interaction with c-Jun Leading to Suppression of p21 Expression in Vascular Smooth Muscle Cells J. Biochem., November 1, 2009; 146(5): 683 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Lyon, J. L. Johnson, H. Williams, G. B. Sala-Newby, and S. J. George Soluble N-Cadherin Overexpression Reduces Features of Atherosclerotic Plaque Instability Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 195 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dwivedi, S. C. Slater, and S. J. George MMP-9 and -12 cause N-cadherin shedding and thereby {beta}-catenin signalling and vascular smooth muscle cell proliferation Cardiovasc Res, January 1, 2009; 81(1): 178 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liebner, M. Corada, T. Bangsow, J. Babbage, A. Taddei, C. J. Czupalla, M. Reis, A. Felici, H. Wolburg, M. Fruttiger, et al. Wnt/{beta}-catenin signaling controls development of the blood-brain barrier J. Cell Biol., November 3, 2008; 183(3): 409 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bedel, A. Negre-Salvayre, S. Heeneman, M.-H. Grazide, J.-C. Thiers, R. Salvayre, and F. Maupas-Schwalm E-Cadherin/{beta}-Catenin/T-Cell Factor Pathway Is Involved in Smooth Muscle Cell Proliferation Elicited by Oxidized Low-Density Lipoprotein Circ. Res., September 26, 2008; 103(7): 694 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Giordano, S. Romano, M. Mallardo, A. D'Angelillo, G. Cali, N. Corcione, P. Ferraro, and M. F. Romano FK506 can activate transforming growth factor-{beta} signalling in vascular smooth muscle cells and promote proliferation Cardiovasc Res, August 1, 2008; 79(3): 519 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hou, K. Okada, C. Okamoto, S. Ueshima, and O. Matsuo Alpha2-Antiplasmin Is a Critical Regulator of Angiotensin II-Mediated Vascular Remodeling Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1257 - 1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Nunes, M. Schmidt, G. Dueck, H. Baarsma, A. J. Halayko, H. A. M. Kerstjens, H. Meurs, and R. Gosens GSK-3/{beta}-catenin signaling axis in airway smooth muscle: role in mitogenic signaling Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1110 - L1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Taurin, N. Sandbo, D. M. Yau, N. Sethakorn, and N. O. Dulin Phosphorylation of {beta}-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1169 - C1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. George Wnt Pathway: A New Role in Regulation of Inflammation Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 400 - 402. [Full Text] [PDF] |
||||
![]() |
E. D. Cohen, Y. Tian, and E. E. Morrisey Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal Development, March 1, 2008; 135(5): 789 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Kirton, N. J. Crofts, S. J. George, K. Brennan, and A. E. Canfield Wnt/{beta}-Catenin Signaling Stimulates Chondrogenic and Inhibits Adipogenic Differentiation of Pericytes: Potential Relevance to Vascular Disease? Circ. Res., September 14, 2007; 101(6): 581 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Couffinhal, P. Dufourcq, and C. Duplaa {beta}-Catenin Nuclear Activation: Common Pathway Between Wnt and Growth Factor Signaling in Vascular Smooth Muscle Cell Proliferation? Circ. Res., December 8, 2006; 99(12): 1287 - 1289. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |